Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 3, 2017, Pages 679-693

  Swaminathan, Ganesh ^a,b   Gadepalli, Venkat S ^c   Stoilov, Ivan ^d   Mecham, Robert P ^d   Rao, Raj R ^c   Ramamurthi, Anand ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF AKRON   (United States)

^c Virginia Commonwealth University   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

abdominal aortic aneurysm; cell therapy; elastin regeneration; elastogenesis; SMC differentiation; smooth muscle cell

Indexed keywords

BLOOD VESSELS; BONE; CELL CULTURE; ELASTIN; MUSCLE; STEM CELLS;

ABDOMINAL AORTIC ANEURYSMS; ANEURYSM GROWTH; BONE MARROW MESENCHYMAL; CELL THERAPY; ELASTIC MATRIX; ELASTIN REGENERATION; ELASTOGENESIS; MARROW MESENCHYMAL STEM CELLS; SMOOTH MUSCLE CELL DIFFERENTIATION; SMOOTH MUSCLE CELLS;

GLYCOPROTEINS;

ELASTIN; GELATINASE A; GELATINASE B; COLLAGEN;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL THERAPY; CONDITIONED MEDIUM; CONTROLLED STUDY; DEVELOPMENT; ELASTOGENESIS; ENZYME ACTIVITY; FOLLOW UP; NONHUMAN; RAT; SMOOTH MUSCLE CELL; ABDOMINAL AORTIC ANEURYSM; ANIMAL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECTS; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHARMACOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; ELASTIN; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STROMAL CELLS; MYOCYTES, SMOOTH MUSCLE; PARACRINE COMMUNICATION; RATS, SPRAGUE-DAWLEY;

EID: 85015040037     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1964     Document Type: Article

References (72)

1. Airhart ND, Brownstein B, Schierding W, et al. 2013; Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg 57(5): 23S.
2. Alcorn HG, Wolfson SK, SuttonTyrrell K, et al. 1996; Risk factors for abdominal aortic aneurysms in older adults enrolled in the cardiovascular health study. Arterioscler Thromb Vasc Biol 16(8): 963–970.
3. Bashur CA, Ramamurthi A. 2012; Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assembly. J Tissue Eng Regen Med 6(9): 673–686.
4. Bashur CA, Ramamurthi A. 2014; Composition of intraperitoneally implanted electrospun conduits modulates cellular elastic matrix generation. Acta Biomater 10(1): 163–172.
5. Bashur CA, Shaffer RD, Dahlgren LA, et al. 2009; Effect of fiber diameter and alignment of electrospun polyurethane meshes on mesenchymal progenitor cells. Tissue Eng Part A 15(9): 2435–2445.
6. Baxter BT, Pearce WH, Waltke EA, et al. 2002; Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (phase II) multicenter study. J Vasc Surg 36(1): 1–12.
7. Bendeck MP, Conte M, Zhang MY, et al. 2002; Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 160(3): 1089–1095.
8. Blank RS, Thompson MM, Owens GK. 1988; Cell cycle versus density dependence of smooth muscle α-actin expression in cultured rat aortic smooth muscle cells. J Cell Biol 107(1): 299–306.
9. Bown MJ, Sutton AJ, Bell PRF, et al. 2002; A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 89(6): 714–730.
10. Bressan GM, Pasqualironchetti I, Fornieri C, et al. 1986; Relevance of aggregation properties of tropoelastin to the assembly and structure of elastic fibers. J Ultrastruct Mol Struct Res 94(3): 209–216.
11. Brewster DC, Cronenwett JL, Hallett JW, et al. 2003; Guidelines for the treatment of abdominal aortic aneurysms – report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 37(5): 1106–1117.
12. Bush RL, Johnson ML, Collins TC, et al. 2006; Open versus endovascular abdominal aortic aneurysm repair in VA hospitals. J Am Coll Surg 202(4): 577–587.
13. Cantinieaux D, Quertainmont R, Blacher S, et al. 2013; Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One 8(8): e69515.
14. Curci JA, Mao DL, Bohner DG, et al. 2000; Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 31(2): 325–341.
15. Dodd BR, Spence RA. 2011; Doxycycline inhibition of abdominal aortic aneurysm growth – a systematic review of the literature. Curr Vasc Pharmacol 9(4): 471–478.
16. Fischer GM, Swain ML, Cherian K. 1980; Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit. Variation in synthesis among major vessels. Atherosclerosis 35(1): 11–20.
17. Fitzpatrick E, Wu Y, Dhadda P, et al. 2013; Co-culture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transpl (Epub ahead of print).
18. Fu XM, Yamawaki-Ogata A, Oshima H, et al. 2013; Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. J Transl Med 11: 175.
19. 2-induced rat aortal expansions as a surrogate culture model for study of elastogenic induction of human aneurysmal cells. Tissue Eng PartA 17(15–16): 1945–1958.
20. Gacchina CE, Deb P, Barth JL, et al. 2011b; Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng Part A 17(13–14): 1699–1711.
21. Han DKM, Liau G. 1992; Identification and characterization of developmentally regulated genes in vascular smooth muscle cells. Circ Res 71(3): 711–719.
22. Hashizume R, Yamawaki-Ogata A, Ueda Y, et al. 2011; Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice. J Vasc Surg 54(6): 1743–1752.
23. Huang NF, Li S. 2008; Mesenchymal stem cells for vascular regeneration. Regen Med 3(6): 877–892.
24. Huffman MD, Curci JA, Moore G, et al. 2000; Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128(3): 429–438.
25. Hughes S, Chan-Ling T. 2004; Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci 45(8): 2795–2806.
26. Hungerford JE, Owens GK, Argraves WS, et al. 1996; Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 178(2): 375–392.
27. Joddar B, Ramamurthi A. 2006; Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 27(15): 2994–3004.
28. Johnson DJ, Robson P, Hew Y, et al. 1995; Decreased elastin synthesis in normal development and in long-term aortic organ and cell-cultures is related to rapid and selective destabilization of mRNA for elastin. Circ Res 77(6): 1107–1113.
29. Johnston WF, Salmon M, Su G, et al. 2013; Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol 33(2): 294–304.
30. Jung T, Schauer U, Heusser C, et al. 1993; Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159(1–2): 197–207.
31. Ko YS, Coppen SR, Dupont E, et al. 2001; Regional differentiation of desmin, connexin43, and connexin45 expression patterns in rat aortic smooth muscle. Arterioscler Thromb Vasc Biol 21(3): 355–364.
32. Kothapalli CR, Taylor PM, Smolenski RT, et al. 2009; Transforming growth factor β1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A 15(3): 501–511.
33. Kuroda T, Yasuda S, Sato Y. 2013; Tumorigenicity studies for human pluripotent stem cell-derived products. Biol Pharmaceut Bull 36(2): 189–192.
34. Kuroo M, Nagai R, Tsuchimochi H, et al. 1989; Developmentally regulated expression of vascular smooth-muscle myosin heavy-chain isoforms. J Biol Chem 264(31): 18272–18275.
35. Kurpinski K, Lam H, Chu JL, et al. 2010; Transforming growth factor-β and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28(4): 734–742.
36. Labarca C, Paigen K. 1980; A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102(2): 344–352.
37. Liu Y, Deng B, Zhao Y, et al. 2013; Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells. Dev Growth Differ 55(5): 591–605.
38. McMahon MP, Faris B, Wolfe BL, et al. 1985; Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. In Vitro Cell Dev Biol 21(12): 674–680.
39. Owens GK. 1995; Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75(3): 487–517.
40. Owens GK, Kumar MS, Wamhoff BR. 2004; Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84(3): 767–801.
41. Park WS, Heo SC, Jeon ES, et al. 2013; Functional expression of smooth muscle-specific ion channels in TGF-β1-treated human adipose-derived mesenchymal stem cells. Am J Physiol Cell Physiol 305(4): C377–391.
42. Parks WC, Pierce RA, Lee KA, et al. 1993; Elastin. In Advances in Molecular and Cell Biology, vol 6, Bittar EE (ed.). Elsevier: Amsterdam; 133–181.
43. Patel M, Yang S. 2010; Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev 6(3): 367–380.
44. Petrinec D, Liao SX, Holmes DR, et al. 1996; Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23(2): 336–346.
45. Pfaffl MW. 2001; A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 29(9): e45.
46. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143–147.
47. Prall AK, Longo GM, Mayhan WG, et al. 2002; Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 35(5): 923–928.
48. Prinssen M, Buskens E, Blankensteijn JD, et al. 2004; Quality of life after endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg 27(2): 121–127.
49. Prussin C, Metcalfe DD. 1995; Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188(1): 117–128.
50. Qi J, Chi L, Maloney M, et al. 2006; Interleukin-1β increases elasticity of human bioartificial tendons. Tissue Eng 12(10): 2913–2925.
51. Rensen SSM, Thijssen V, De Vries CJ, et al. 2002; Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res 55(4): 850–863.
52. Ross JJ, Hong ZG, Willenbring B, et al. 2006; Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 116(12): 3139–3149.
53. Rubach M, Adelmann R, Haustein M, et al. 2014; Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem-cell derived cardiomyocyte clusters into myocardial tissue. Stem Cells Dev 23(6): 643–653.
54. Ruijter JM, Ramakers C, Hoogaars WMH, et al. 2009; Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37(6): e45.
55. Selle JG, Robicsek F, Daugherty HK, et al. 1979; Thoracoabdominal aortic aneurysms. A review and current status. Ann Surg 189(2): 158–164.
56. Shanahan CM, Weissberg PL, Metcalfe JC. 1993; Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73(1): 193–204.
57. Shi J, Wang A, Sen S, et al. 2012; Insulin induces production of new elastin in cultures of human aortic smooth muscle cells. Am J Pathol 180(2): 715–726.
58. Sivaraman B, Ramamurthi A. 2013; Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. Acta Biomater 9(5): 6511–6525.
59. Song M, Heo J, Chun JY, et al. 2014; The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder. Stem Cells Dev 23(6): 654–663.
60. Starcher B. 2001; A ninhydrin-based assay to quantitate the total protein content of tissue samples. Anal Biochem 292(1): 125–129.
61. Stegemann H, Stalder K. 1967; Determination of hydroxyproline. Clin Chim Acta 18(2): 267–273.
62. Swee MH, Parks WC, Pierce RA. 1995; Developmental regulation of elastin production. Expression of tropoelastin pre-mRNA persists after down-regulation of steady-state mRNA levels. J Biol Chem 270(25): 14899–14906.
63. Thompson RW. 2002; Detection and management of small aortic aneurysms. N Engl J Med 346(19): 1484–1486.
64. Treharne GD, Boyle JR, Goodall S, et al. 1999; Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg 86(8): 1053–1058.
65. Van Eys GJJM, Voller MCW, Timmer EDJ, et al. 1997; Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct 22(1): 65–72.
66. Venkataraman L, Bashur CA, Ramamurthi A. 2014; Impact of cyclic stretch on induced elastogenesis within collagenous conduits. Tissue Eng Part A 20(9–10): 1403–1415.
67. Venkataraman L, Ramamurthi A. 2011; Induced elastic matrix deposition within three-dimensional collagen scaffolds. Tissue Eng Part A 17(21–22): 2879–2889.
68. Wagenseil JE, Mecham RP. 2007; New insights into elastic fiber assembly. Birth Defects Res C Embryo Today 81(4): 229–240.
69. Wills A, Thompson MM, Crowther M, et al. 1996; Pathogenesis of abdominal aortic aneurysms – cellular and biochemical mechanisms. Eur J Vasc Endovasc Surg 12(4): 391–400.
70. Xie C-Q, Huang H, Wei S, et al. 2009; A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev 18(5): 741–748.
71. Xu J, Ehrman B, Graham LM, et al. 2012; Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice. J Surg Res 178(1): 512–518.
72. Zhang X, Shan P, Jiang G, et al. 2006; Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116(11): 3050–3059.